Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
6.18
↑ 131% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-19.84
Historical baseline
PeriodValueYoY Change
20256.18+465.6%
2024-1.69-12.8%
2023-1.50-109.4%
2022-0.72+53.4%
2021-1.54+90.2%
2020-15.68+61.0%
2019-40.21+34.8%
2018-61.67+0.1%
2017-61.73-